No mutations in the GATA-1 gene detected in patients with acquired essential thrombocythemia

Haematologica

Volumn 89, Issue 5, 2004, Pages 613-615

  Gandini, Domenica ^a   Allen, Anthony J R ^a   Nash, Michael J ^a   Linch, David C ^a   Gale, Rosemary E ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Essential thrombocythemia; GATA 1; Polymorphisms

Indexed keywords

DNA FRAGMENT; TRANSCRIPTION FACTOR GATA 1;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; DOWN SYNDROME; FAMILIAL DISEASE; FEMALE; GATA 1 GENE; GENE; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GENETIC SCREENING; HUMAN; HUMAN CELL; MOLECULAR CLONING; MUTATIONAL ANALYSIS; NEUTROPHIL; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTHEMIA; THROMBOCYTOPENIA;

ANIMALS; FEMALE; GATA1 TRANSCRIPTION FACTOR; HL-60 CELLS; HUMANS; MICE; MICE, KNOCKOUT; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; THROMBOCYTHEMIA, HEMORRHAGIC;

EID: 2542439745     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. VisvaderJ, Adams JM. Megakaryocytic differentiation induced in 416B myeloid cells by GATA-2 and GATA-3 transgenes or 5-azacytidine is tightly coupled to GATA-1 expression. Blood 1993;82:1493-501.
2. Vyas P, Ault K, Jackson CW, Orkin SH, Shivdasani RA. Consequences of GATA-1 deficiency in megalkaryocytes and platelets. Blood 1999;93:2867-75.
3. Nichols KE, Crispino JD, Poncz, M, White JG, Orkin SH, Maris JM, et al. Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1. Nat Gen 2000;24:266-70.
4. Mehaffey MG, Newton AL, Gandhi MJ, Crossley M, Drachman JG. X-linked thrombocytopenia caused by a novel mutation of GATA-1. Blood 2002;98:2681-8.
5. Freson K, Devriendt K, Matthijs G, Van Hoof A, De Vos R, Thys C, et al. Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation. Blood 2001;98:85-92.
6. Freson K, Matthijs G, Thys C, Marien P, Hoylaerts MF, Vermylen J, et al. Different substitutions at residue D218 of the X-linked transcription factor GATA1 lead to altered clinical severity of macrotbrombocytopenia and anemia and are associated with variable skewed X inactivation. Hum Mol Gen 2002;11:147-52.
7. Yu C, Niakan KK, Matsushita M, Stamatoyannopoulos G, Orkin SH, Raskind WH. X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interaction. Blood 2002;100:2040-5.
8. Gurbuxani S, Vyas P, Crispino JD. Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome. Blood 2004;103:399-406.
9. Gale RE. Pathogenic markers in essential thrombocythemia. Curr Hematol Rep 2003;2:242-7.
10. Harrison CN, Gale RE Machin SJ, Linch DC. A large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications. Blood 1999;93:417-24.
11. Vyas P, McDevitt MA, Cantor AB, Katz SG, Fujiwara Y, Orkin SH. Different sequence requirements for expression in erythroid and megalkaryocytic cells within a regulatory element upstream of the GATA-1 gene. Development 1999;126:2799-811.